Zoetis Inc.
ZTS
$174.06
$0.350.20%
| Weiss Ratings | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B | |||
| Rating Factors | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Price History | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.53% | |||
| 30-Day Total Return | 5.07% | |||
| 60-Day Total Return | -11.77% | |||
| 90-Day Total Return | -12.50% | |||
| Year to Date Total Return | -11.51% | |||
| 1-Year Total Return | -3.18% | |||
| 2-Year Total Return | 9.74% | |||
| 3-Year Total Return | 2.38% | |||
| 5-Year Total Return | 72.81% | |||
| 52-Week High % Change | -13.80% | |||
| 52-Week Low % Change | 20.21% | |||
| Price | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $201.92 | |||
| 52-Week Low Price | $144.80 | |||
| 52-Week Low Price (Date) | Apr 22, 2024 | |||
| 52-Week High Price (Date) | Dec 14, 2023 | |||
| Valuation | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 79.42B | |||
| Enterprise Value | 84.24B | |||
| Price/Earnings (TTM) | 33.56 | |||
| Earnings Per Share (TTM) | 5.19 | |||
| Earnings Per Share Growth | 17.40% | |||
| Price/Earnings To Growth | 1.93 | |||
| Price/Sales (TTM) | 9.14 | |||
| Price/Book (Q) | 15.72 | |||
| Enterprise Value/Revenue (TTM) | 9.65 | |||
| Price | $174.06 | |||
| Enterprise Value/EBITDA (TTM) | 23.62 | |||
| Enterprise Value/EBIT | 26.79 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 458.80M | |||
| Dividend Yield | 0.93% | |||
| Div. Per Share (Most Recent) | $0.43 | |||
| Dividend Per Share (TTM) | $1.61 | |||
| Payout Ratio (TTM) | 29.95% | |||
| Dividend Per Share (Most Recent) | $0.43 | |||
| Company Info | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 973 822 7000 | |||
| Address | 10 Sylvan Way Parsippany, NJ 07054 | |||
| Website | www.zoetis.com | |||
| Country | United States | |||
| Year Founded | 1952 | |||
| Profitability | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 36.00% | |||
| Profit Margin | 27.37% | |||
| Management Effectiveness | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 13.99% | |||
| Return on Equity | 50.05% | |||
| Income Statement | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 8.73B | |||
| Total Revenue (TTM) | 8.73B | |||
| Revenue Per Share | $19.04 | |||
| Gross Profit (TTM) | 6.12B | |||
| EBITDA (TTM) | 3.57B | |||
| EBIT (TTM) | 3.15B | |||
| Net Income (TTM) | 2.39B | |||
| Net Income Avl. to Common (TTM) | 2.39B | |||
| Total Revenue Growth (Q YOY) | 9.50% | |||
| Earnings Growth (Q YOY) | 8.71% | |||
| EPS Diluted (TTM) | 5.19 | |||
| EPS Diluted Growth (Q YOY) | 9.91% | |||
| Balance Sheet | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.98B | |||
| Cash Per Share (Q) | $4.30 | |||
| Total Current Assets (Q) | 6.36B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.05B | |||
| Current Ratio (Q) | 3.331 | |||
| Book Value Per Share (Q) | $11.07 | |||
| Total Assets (Q) | 14.35B | |||
| Total Current Liabilities (Q) | 1.91B | |||
| Total Debt (Q) | 6.80B | |||
| Total Liabilities (Q) | 9.30B | |||
| Total Common Equity (Q) | 5.06B | |||
| Cash Flow | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -692.00M | |||
| Cash from Financing (TTM) | -1.83B | |||
| Net Change in Cash (TTM) | -134.00M | |||
| Levered Free Cash Flow (TTM) | 1.49B | |||
| Cash from Operations (TTM) | 2.40B | |||
